Nuveen’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.8M Sell
453,342
-26,689
-6% -$4.91M 0.02% 481
2026
Q1
$90.6M Sell
480,031
-675,646
-58% -$142M 0.02% 423
2025
Q4
$230M Buy
1,155,677
+124,223
+12% +$25.1M 0.06% 240
2025
Q3
$209M Buy
1,031,454
+338,827
+49% +$60.1M 0.06% 258
2025
Q2
$122M Sell
692,627
-932,271
-57% -$140M 0.03% 351
2025
Q1
$219M Buy
1,624,898
+61,314
+4% +$8.07M 0.07% 240
2024
Q4
$197M Sell
1,563,584
-86,563
-5% -$12.9M 0.06% 261
2024
Q3
$274M Buy
1,650,147
+259,607
+19% +$39.3M 0.08% 211
2024
Q2
$185M Buy
1,390,540
+871,267
+168% +$105M 0.05% 266
2024
Q1
$54.6M Sell
519,273
-22,568
-4% -$2.03M 0.02% 602
2023
Q4
$40.9M Buy
541,841
+377
+0.1% +$23.9K 0.01% 703
2023
Q3
$35.7M Sell
541,464
-42,055
-7% -$3.14M 0.01% 714
2023
Q2
$47.5M Buy
583,519
+33,206
+6% +$2.36M 0.02% 591
2023
Q1
$32.7M Buy
550,313
+15,455
+3% +$859K 0.01% 752
2022
Q4
$26.1M Sell
534,858
-369,576
-41% -$17.1M 0.01% 870
2022
Q3
$46.7M Sell
904,434
-25,897
-3% -$1.54M 0.02% 549
2022
Q2
$48.9M Sell
930,331
-586,107
-39% -$40.8M 0.02% 566
2022
Q1
$133M Buy
1,516,438
+224,825
+17% +$18.5M 0.04% 357
2021
Q4
$106M Buy
1,291,613
+324,177
+34% +$23.7M 0.03% 421
2021
Q3
$64.3M Sell
967,436
-93,541
-9% -$6.63M 0.02% 570
2021
Q2
$71.1M Buy
1,060,977
+103,051
+11% +$6.39M 0.02% 595
2021
Q1
$49.8M Buy
957,926
+17,161
+2% +$868K 0.02% 729
2020
Q4
$37.6M Buy
940,765
+84,993
+10% +$2.74M 0.01% 856
2020
Q3
$21M Buy
855,772
+223,169
+35% +$5.7M 0.01% 1030
2020
Q2
$11.5M Sell
632,603
-62,134
-9% -$1.22M ﹤0.01% 1397
2020
Q1
$10M Sell
694,737
-401,343
-37% -$11.5M ﹤0.01% 1292
2019
Q4
$41.7M Buy
1,096,080
+511,350
+87% +$15.3M 0.02% 763
2019
Q3
$12.9M Buy
584,730
+79,599
+16% +$1.7M 0.01% 1400
2019
Q2
$10.4M Buy
+505,131
New +$11.6M ﹤0.01% 1580
2017
Q2
Sell
-43,543
Closed -$771K 1300
2017
Q1
$771K Buy
43,543
+11,460
+36% +$213K ﹤0.01% 1048
2016
Q4
$476K Hold
32,083
﹤0.01% 1323
2016
Q3
$727K Sell
32,083
-7,707
-19% -$201K ﹤0.01% 1167
2016
Q2
$1.1M Buy
+39,790
New +$1.18M 0.01% 999
2015
Q4
Sell
-18,708
Closed -$691K 1571
2015
Q3
$691K Sell
18,708
-2,453
-12% -$127K ﹤0.01% 1226
2015
Q2
$1.23M Buy
21,161
+2,453
+13% +$125K 0.01% 1060
2015
Q1
$926K Sell
18,708
-34,750
-65% -$1.62M 0.01% 1197
2014
Q4
$2.71M Buy
53,458
+1,759
+3% +$91.9K 0.02% 729
2014
Q3
$3.07M Buy
51,699
+13,736
+36% +$766K 0.02% 662
2014
Q2
$1.78M Buy
37,963
+31,068
+451% +$1.4M 0.01% 867
2014
Q1
$295K Sell
6,895
-535
-7% -$23.6K ﹤0.01% 1432
2013
Q4
$313K Buy
+7,430
New +$323K ﹤0.01% 1402
2013
Q3
Sell
-12,359
Closed -$570K 1566
2013
Q2
$570K Buy
+12,359
New +$553K ﹤0.01% 1273

Other funds holding THC

Nuveen's THC Position: Q2 2026 in Review

Nuveen reduced its Tenet Healthcare (THC) stake by 5.6% in Q2 2026, selling an estimated $4.91M and leaving 453,342 shares worth $84.8M. The position accounts for 0.02% of the portfolio, ranked #481.

Nuveen first reported a position in THC in Q2 2013 and has held it in 42 quarters since. The position peaked at $274M in Q3 2024. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Nuveen held 453,342 shares of Tenet Healthcare worth $84.8M as of Q2 2026.
  • Nuveen sold 26,689 Tenet Healthcare shares in Q2 2026, an estimated $4.91M.
  • Tenet Healthcare made up 0.02% of Nuveen's portfolio in Q2 2026, its #481 holding.
  • Nuveen first reported a position in Tenet Healthcare in Q2 2013 and has held it in 42 quarters since.
  • Nuveen's Tenet Healthcare position peaked at $274M in Q3 2024.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.